RICHA KAPIL: Open Payments
NPI 1407317712 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 41 payments from 12 companies in 2025. Trend: 2023 $690 · 2024 $1,181 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $295 |
| Amgen Inc. | 10 | $137 |
| GlaxoSmithKline, LLC. | 7 | $124 |
| SHIELD THERAPEUTICS INC | 4 | $94 |
| Astellas Pharma US Inc | 3 | $86 |
| Novo Nordisk Inc | 2 | $49 |
| Exact Sciences Corporation | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $23 |
Products named: FARXIGA, AIRSUPRA, SHINGRIX, ACCRUFER, Veozah, EVENITY, OTEZLA, Cologuard Collection Kit.
Industry payments across GA — which companies pay providers there.
